Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb 2:16:109.
doi: 10.1186/s12889-016-2785-7.

Trends in childhood pneumococcal vaccine coverage in Shanghai, China, 2005-2011: a retrospective cohort study

Matthew L Boulton  1   2 , Nithin S Ravi  3 , Xiaodong Sun  4 , Zhuoying Huang  4 , Abram L Wagner  5
Affiliations

Trends in childhood pneumococcal vaccine coverage in Shanghai, China, 2005-2011: a retrospective cohort study

Matthew L Boulton et al. BMC Public Health. .

Abstract

Background: In China, the pneumococcal conjugate vaccine (PCV7) and the pneumococcal polysaccharide vaccine (PPSV23) are not offered under the government's Expanded Program on Immunization and are instead administered for a fee. PCV7 is more effective and covers more serotypes associated with invasive disease in children, but is also more expensive, than PPSV23. Because of their expense, there is concern that these vaccines, especially PCV7, have low uptake particularly among non-locals, migrants from outside of Shanghai. This paper characterizes the differential coverage of PCV7 and PPSV23 between locals and non-locals in Shanghai, and illustrates coverage trends over time.

Methods: In this retrospective cohort study, children born between 2005 and 2011 were sampled from the Shanghai Immunization Program Information System. Bivariate and multivariable analyses examined the relationships between demographic characteristics, residency status (non-locals vs locals), and vaccination coverage.

Results: PPSV23 coverage (29.8 %) among children over 2 years of age was higher than PCV7 coverage (10.1 %) for locals and non-locals. Uptake of PCV7 increased substantially after children were 2 years of age. Overall, non-local populations had higher PPSV23 coverage (OR: 1.34; 98 % CI: 1.22, 1.46) but lower PCV7 coverage (OR: 0.617, 98 % CI: 0.547, 0.695) than locals.

Conclusions: There is a need for increasing overall pneumococcal coverage in Shanghai children, particularly with the more effective PCV7 vaccine. Morbidity and mortality due to invasive pneumococcal disease for children <1 year of age are unlikely to be mitigated if the current age-related vaccination patterns are not improved.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Coverage of pneumococcal conjugate vaccine (PCV7) and pneumococcal polysaccharide vaccine (PPSV23) by birth year and residency status, Shanghai Immunization Program Information System, July 2012
Fig. 2
Fig. 2
Cumulative vaccination coverage of pneumococcal conjugate vaccine (PCV7) and pneumococcal polysaccharide vaccine (PPSV23) by residency status, Shanghai Immunization Program Information System, July 2012
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Chen Y, Deng W, Wang S, Mo Q, Jia H, Wang Q, et al. Burden of pneumonia and meningitis caused by Streptococcus pneumoniae in China among children under 5 years of age: A systematic literature review. PLoS One. 2011;6(11):e27333. doi: 10.1371/journal.pone.0027333. - DOI - PMC - PubMed
    1. O’Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374(9693):893–902. doi: 10.1016/S0140-6736(09)61204-6. - DOI - PubMed
    1. Grabenstein JD, Klugman KP. A century of pneumococcal vaccination research in humans. Clin Microbiol Infect. 2012;18(Suppl. 5):15–24. doi: 10.1111/j.1469-0691.2012.03943.x. - DOI - PubMed
    1. Centers for Disease Control and Prevention. Pneumococcal disease. In Epidemiology and Prevention of Vaccine-Preventable Diseases. 13th edition. Edited by Hamborsky J, Kroger A, Wolfe S. Washington D.C.: Public Health Foundation; 2015. p.279–296.
    1. Burkitt L. Pfizer to Cease Vaccine Sales Business in China. Wall Str J. 2015. Available: http://www.wsj.com/articles/pfizer-to-cease-vaccine-sales-business-in-ch.... Accessed 19 April 2015.

Publication types